Updates

Acal

November 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Ahead of reporting on 27 November, Acal said that trading in H1 was 27% ahead of last year (3% organic) and up 20% on constant currency. Group orders are up 19% year-on-year and gross margins are trending up.All the design & manufacturing businesses have seen healthy like-for-like growth including Noratel, the specialist supplier of transformers for high end applications, which was acquired in July. Cross-selling programmes are now being exploited between the Group's three transformer businesses (Noratel, Myrra and Acal BFi). Elsewhere, Acal’s third party custom distribution business has also seen improving demand driven by Germany and Italy although the UK distribution market is slow.Adjusting ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Prezzo - Early stage bid talks with ASK-owner

Velocys

Acal (May 2016)

Acal (March 2016)

Acal (February 2016)

ACAL (December 2015)

Acal (July 2015)

Acal - Eps forecasts upgraded by 5% following acquisition (February 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X